P05: DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE VERSUS LENALIDOMIDE AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 POLLUX TRIAL

• MA Dimopoulos,
• A Oriol,
• H Nahi,
• J San-Miguel,
• NJ Bahlis,
• SZ Usmani,
• N Rabin,
• RZ Orlowski,
• K Suzuki,
• T Plesner,
• SS Yoon,
• D Ben Yehuda,
• PG Richardson,
• H Goldschmidt,
• D Reece,
• T Ahmadi,
• X Qin,
• W Garvin Mayo,
• X Gai,
• J Carey,
• R Carson,
• P Moreau

Affiliations

MA Dimopoulos

1 Athens, Greece

A Oriol

2 Barcelona, Spain

H Nahi

3 Stockholm, Sweden

J San-Miguel

4 Pamplona, Spain

NJ Bahlis

5 Calgary, AB, Canada

SZ Usmani

6 New York, NY, USA

N Rabin

7 London, United Kingdom

RZ Orlowski

8 Houston, TX, USA

K Suzuki

9 Tokyo, Japan

T Plesner

10 Vejle, Denmark

SS Yoon

11 Seoul, South Korea

D Ben Yehuda

12 Jerusalem, Israel

PG Richardson

13 Boston, MA, USA

H Goldschmidt

14 Heidelberg, Germany

D Reece

15 Toronto, Canada

T Ahmadi

16 Plainsboro, NJ, USA

X Qin

17 Spring House, PA, USA

W Garvin Mayo

18 Raritan, NJ, USA

X Gai

19 Beijing, China

J Carey

17 Spring House, PA, USA

R Carson

17 Spring House, PA, USA

P Moreau

20 Nantes, France